Ezetimibe Tablets 10 mg (Ezetimibe)

Adult dosage

The recommended dosage of this medication is 10 mg once daily, taken without regard to meals. When co-administered with HMG-CoA reductase inhibitors, therapy should start at the recommended initial dose of HMG-CoA reductase inhibitors along with this medication, maintaining the HMG-CoA reductase inhibitor dose if the patient is already on a high dose. This medication

This medication should not be used by individuals with an allergy to any ingredients of this medication. Patients with liver function issues or significantly elevated liver enzyme levels should not take this medication in combination with certain other drugs. Women who are pregnant or breastfeeding are advised against using this medication in combination with specific lipid-lowering agents. Patients with severely impaired liver function, gallbladder diseases, or severe kidney dysfunction should not take this medication with specific drugs. Individuals with lactose intolerance or those genetically unable to digest lactose should not take this medication. The use of this medication is not recommended in patients with moderate to severe liver impairment. While this medication is generally considered safe, side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur. When taken in conjunction with other lipid-lowering agents, liver enzyme levels may increase, necessitating regular liver function tests. If muscle pain or weakness occurs, consultation with a physician should be sought immediately, and drug use should be discontinued if severe. Patients with severely impaired kidney function can use this medication without special dosage adjustments, but care should be taken for those with weakened renal function. There may be interactions when used with other medications, so any existing medications should be disclosed to a physician or pharmacist. Women who are pregnant or planning to become pregnant should consult a doctor before taking this medication. Women who are breastfeeding should exercise caution as this medication may be excreted in breast milk and could affect the infant. Children under 6 years of age are advised not to take this medication, while children and adolescents over 6 years should do so under physician's guidance. Elderly patients can generally use this medication, but care is needed due to age-related sensitivities. In case of overdose, there are no specific antidotes, and appropriate treatment should be provided based on symptoms. This medication should be kept out of reach of children and not transferred to other containers.

Serious side effects

Urticaria, swelling, anaphylaxis, hypersensitivity reactions including rash and angioedema, hepatitis, thrombocytopenia, pancreatitis, severe cutaneous adverse reactions (SCARs) including Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell syndrome), eosinophilia with systemic symptoms drug reaction (DRESS), severe skin reactions including polymorphic erythema, drug-induced liver injury, myopathy, rhabdomyolysis, liver function abnormalities (ALT,

Mild side effects

Headache, abdominal pain, diarrhea, fatigue, constipation, bloating, nausea, dizziness, paresthesia, depression, palpitations, flushing, cough, phlegm, runny nose, limb pain, joint pain, diabetes, hypoglycemia, anemia, splenomegaly, sweating, rash, itching, upper respiratory infection, conjunctival congestion, vomiting, gastritis, dry mouth, discomfort in the epigastric region, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, increased creatine phosphokinase (CPK) in the blood.

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius. Proper storage can maintain the effectiveness and safety of the medication.

Appearance

White to almost white oblong tablets

Package unit

30 tablets/box [(10 tablets/PTP*3)]